Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Rapid Therapeutic Science Laboratories, Inc. (RTSL) Other Operating Expenses (2018 - 2023)

Rapid Therapeutic Science Laboratories' Other Operating Expenses history spans 6 years, with the latest figure at $5993.0 for Q2 2023.

  • For Q2 2023, Other Operating Expenses changed 0.0% year-over-year to $5993.0; the TTM value through Jun 2023 reached $23972.0, down 98.71%, while the annual FY2022 figure was $23972.0, 98.72% down from the prior year.
  • Other Operating Expenses for Q2 2023 was $5993.0 at Rapid Therapeutic Science Laboratories, roughly flat from $5993.0 in the prior quarter.
  • Across five years, Other Operating Expenses topped out at $1.8 million in Q4 2021 and bottomed at -$15266.0 in Q4 2022.
  • The 5-year median for Other Operating Expenses is $9246.5 (2019), against an average of $143007.7.
  • The largest YoY upside for Other Operating Expenses was 393.25% in 2022 against a maximum downside of 100.83% in 2022.
  • A 5-year view of Other Operating Expenses shows it stood at $12500.0 in 2019, then skyrocketed by 119.34% to $27418.0 in 2020, then soared by 6637.02% to $1.8 million in 2021, then plummeted by 100.83% to -$15266.0 in 2022, then surged by 139.26% to $5993.0 in 2023.
  • Per Business Quant, the three most recent readings for RTSL's Other Operating Expenses are $5993.0 (Q2 2023), $5993.0 (Q1 2023), and -$15266.0 (Q4 2022).